Your browser doesn't support javascript.
loading
PPM1D mutations appear in complete remission after exposure to chemotherapy without predicting emerging AML relapse.
Al Hinai, Adil S A; Grob, Tim; Rijken, Melissa; Kavelaars, François G; Zeilemaker, Annelieke; Erpelinck-Verschueren, Claudia A J; Sanders, Mathijs A; Löwenberg, Bob; Jongen-Lavrencic, Mojca; Valk, Peter J M.
Affiliation
  • Al Hinai ASA; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Grob T; National Genetic Center, Ministry of Health, Muscat, Sultanate of Oman.
  • Rijken M; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Kavelaars FG; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Zeilemaker A; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Erpelinck-Verschueren CAJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Sanders MA; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Löwenberg B; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Jongen-Lavrencic M; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Valk PJM; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Leukemia ; 35(9): 2693-2697, 2021 09.
Article in En | MEDLINE | ID: mdl-33589749

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Protein Phosphatase 2C / Mutation / Neoplasm Recurrence, Local Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2021 Type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Protein Phosphatase 2C / Mutation / Neoplasm Recurrence, Local Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2021 Type: Article Affiliation country: Netherlands